Acumen LLC, doing business as Medric, was awarded a $25.7 million delivery order against the Department of Health and Human Services' BEST Initiative master IDIQ contract to conduct surveillance activities in support of safety and effectiveness efforts for COVID-19 biologics. Under the three-year time-and-materials contract, Medric will provide data tools and infrastructure to the Food and Drug Administration for post-market surveillance of vaccines, therapeutics and diagnostics aimed at combating the COVID-19 pandemic. Performance will take place in Burlingame, California. No set aside designation was specified.
Generated 12/25/23, 5:29 AM